Identification of potential inhibitors of human aldose reductase from natural compounds of Vietnamese medicinal plants using in silico approaches
Tóm tắt: 56
| 
PDF: 16 
##plugins.themes.academic_pro.article.main##
Author
Từ khóa:
Aldose reductase
diabetic complications
Vietnamese medicinal plants
molecular docking
Tóm tắt
Aldose reductase is a crucial component of the polyol pathway and catalyzes the NADPH-dependent reduction of glucose to sorbitol. The high activity of Aldose reductase is involved in the development and pathophysiology of diabetes complications. Therefore, this enzyme has been identified as an important target for treatment of these complications. In this study, we performed in silico investigations on natural compounds derived from Vietnamese medicinal plants to identify potential inhibitors of human Aldose reductase. The results showed that out of 307 compounds, 15 compounds were identified as potential Aldose reductase inhibitors with high docking scores and good pharmacokinetics properties. Among them, eight compounds had been proven to inhibit Aldose reductase. The other seven compounds, including Apigenin-7-O-glucuronide, 4′,7-dihydroxy-3′-methoxyflavan, N-feruloylserotonin, N-(p-Coumaroyl) Serotonin, Rosavin, Apigenin-7,4'-dimethyl ether, and Perlolyrine, should be further investigated to develop potential Aldose reductase inhibitors for the treatment of diabetes complications.
Tài liệu tham khảo
-
[1] V. Ramana and S. K. Srivastava, “Aldose reductase: A novel therapeutic target for inflammatory pathologies”, Int J Biochem Cell Biol, vol. 42, no. 1, pp. 17–20, 2010, doi: 10.1016/J.BIOCEL.2009.09.009.
[2] A. Kumar and G. B. Reddy, “Focus on Molecules: Aldose reductase”, Exp Eye Res, vol. 85, no. 6, pp. 739–740, 2007, doi: 10.1016/j.exer.2006.08.002.
[3] Maccari and R. Ottanà, “Targeting Aldose Reductase for the Treatment of Diabetes Complications and Inflammatory Diseases: New Insights and Future Directions”, J Med Chem, vol. 58, no. 5, pp. 2047–2067, 2015, doi: 10.1021/jm500907a.
[4] Zhu and C. Zhu, “Aldose Reductase Inhibitors as Potential Therapeutic Drugs of Diabetic Complications”, Diabetes Mellitus - Insights and Perspectives, Jan. 2013, doi: 10.5772/54642.
[5] Antony and R. Vijayan, “Identification of Novel Aldose Reductase Inhibitors from Spices: A Molecular Docking and Simulation Study”, PLoS One, vol. 10, no. 9, p. e0138186, 2015, doi: 10.1371/JOURNAL.PONE.0138186.
[6] Veeresham, A. R. Rao, and K. Asres, “Aldose Reductase Inhibitors of Plant Origin”, Phytotherapy Research, vol. 28, no. 3, pp. 317–333, 2014, doi: 10.1002/PTR.5000.
[7] Shaker, S. Ahmad, J. Lee, C. Jung, and D. Na, “In silico methods and tools for drug discovery”, Comput Biol Med, vol. 137, p. 104851, 2021, doi: 10.1016/J.COMPBIOMED.2021.104851.
[8] Guan et al., “ADMET-score – a comprehensive scoring function for evaluation of chemical drug-likeness”, Medchemcomm, vol. 10, no. 1, pp. 148–157, 2019, doi: 10.1039/C8MD00472B.
[9] Porro et al., “Functional and Therapeutic Potential of Cynara scolymus in Health Benefits”, Nutrients 2024, Vol. 16, Page 872, vol. 16, no. 6, p. 872, 2024, doi: 10.3390/NU16060872.
[10] N. Pham, T. T. T. Nguyen, and H. Nguyen-Ngoc, “Ethnopharmacology, Phytochemistry, and Pharmacology of Syzygium nervosum”, Evidence-based Complementary and Alternative Medicine, vol. 2020, 2020, doi: 10.1155/2020/8263670.
[11] Gopalakrishnan, K. Doriya, and D. S. Kumar, “Moringa oleifera: A review on nutritive importance and its medicinal application”, Food Science and Human Wellness, vol. 5, no. 2, pp. 49–56, 2016, doi: 10.1016/J.FSHW.2016.04.001.
[12] Asadujjaman, A. U. l. Mishuk, M. A. s. Hossain, and U. K. u. Karmakar, “Medicinal potential of Passiflora foetida L. plant extracts: biological and pharmacological activities”, J. Integr Med, vol. 12, no. 2, pp. 121–126, 2014, doi: 10.1016/S2095-4964(14)60017-0.
[13] U. Rehman, K. Choe, and H. H. Yoo, “Review on a Traditional Herbal Medicine, Eurycoma longifolia Jack (Tongkat Ali): Its Traditional Uses, Chemistry, Evidence-Based Pharmacology and Toxicology”, Molecules 2016, Vol. 21, Page 331, vol. 21, no. 3, p. 331, 2016, doi: 10.3390/MOLECULES21030331.
[14] Ramírez and J. Caballero, “Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data?”, Molecules 2018, Vol. 23, Page 1038, vol. 23, no. 5, p. 1038, 2018, doi: 10.3390/MOLECULES23051038.
[15] X. Ruiz et al., “Structural Determinants of the Selectivity of 3-Benzyluracil-1-acetic Acids toward Human Enzymes Aldose Reductase and AKR1B10”, ChemMedChem, vol. 10, no. 12, pp. 1989–2003, 2015, doi: 10.1002/CMDC.201500393.
[16] Muthenna, P. Suryanarayana, S. K. Gunda, J. M. Petrash, and G. B. Reddy, “Inhibition of aldose reductase by dietary antioxidant curcumin: Mechanism of inhibition, specificity and significance”, FEBS Lett, vol. 583, no. 22, pp. 3637–3642, 2009, doi: 10.1016/J.FEBSLET.2009.10.042.
[17] N. Yoon, M. Y. Lee, J. K. Kim, H. W. Suh, and S. S. Lim, “Aldose reductase inhibitory compounds from xanthium strumarium”, Arch Pharm Res, vol. 36, no. 9, pp. 1090–1095, 2013, doi: 10.1007/S12272-013-0123-5.
[18] M. Li, S. H. Hwang, B. G. Kang, J. S. Hong, and S. S. Lim, “Inhibitory Effects of Colocasia esculenta (L.) Schott Constituents on Aldose Reductase”, Molecules 2014, Vol. 19, Pages 13212-13224, vol. 19, no. 9, pp. 13212–13224, 2014, doi: 10.3390/MOLECULES190913212.
[19] H. Paek, K. H. Shin, Y.-H. Kang, J.-Y. Lee, and S. S. Lim, “Rapid Identification of Aldose Reductase Inhibitory Compounds from Perilla frutescens”, Biomed Res Int, vol. 2013, pp. 1–8, 2013, doi: 10.1155/2013/679463.
[20] Yang, L. Kan, L. Wu, Y. Zhu, and Q. Wang, “Effect of baicalin on renal function in patients with diabetic nephropathy and its therapeutic mechanism”, Exp Ther Med, vol. 17, no. 3, pp. 2071–2076, 2019, doi: 10.3892/ETM.2019.7181.
[21] Soda et al., “Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo–keto reductase 1B10”, Eur J Med Chem, vol. 48, pp. 321–329, 2012, doi: 10.1016/J.EJMECH.2011.12.034.
[22] K. Kim, Y. S. Lee, S. H. Kim, Y. S. Bae, and S. S. Lim, “Inhibition of Aldose Reductase by Phenylethanoid Glycoside Isolated from the Seeds of Paulownia coreana”, Biol Pharm Bull, vol. 34, no. 1, pp. 160–163, 2011, doi: 10.1248/BPB.34.160.
[23] S. Chaudhry, J. Cabrera, H. R. Juliani, and S. D. Varma, “Inhibition of human lens aldose reductase by flavonoids, sulindac and indomethacin”, Biochem Pharmacol, vol. 32, no. 13, pp. 1995–1998, 1983, doi: 10.1016/0006-2952(83)90417-3.
[24] B. Reddy, P. Muthenna, C. Akileshwari, M. Saraswat, and J. M. Petrash, “Inhibition of aldose reductase and sorbitol accumulation by dietary rutin”, Curr Sci, vol. 101, no. 9, pp. 1191–1197, 2011, Accessed: Jan. 29, 2024. [Online]. Available: https://www.jstor.org/stable/24079610
[25] Gupta, N. Singh, and A. S. Jaggi, “Alkaloids as Aldose Reductase Inhibitors, with Special Reference to Berberine”, J. Altern. Complement. Med vol. 20, no. 3, pp. 195–205, 2014, doi: 10.1089/ACM.2013.0088.
[26] Kato, H. Yasuko, H. Goto, J. Hollinshead, R. J. Nash, and I. Adachi, “Inhibitory effect of rhetsinine isolated from Evodia rutaecarpa on aldose reductase activity”, Phytomedicine, vol. 16, no. 2–3, pp. 258–261, 2009, doi: 10.1016/J.PHYMED.2007.04.008.
[27] Urzhumtsev et al., “A ‘specificity’ pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil”, Structure, vol. 5, no. 5, pp. 601–612, 1997, doi: 10.1016/S0969-2126(97)00216-5.
[28] Wang et al., “Rosavin: Research Advances in Extraction and Synthesis, Pharmacological Activities and Therapeutic Effects on Diseases of the Characteristic Active Ingredients of Rhodiola rosea L.”, Molecules 2023, Vol. 28, Page 7412, vol. 28, no. 21, p. 7412, 2023, doi: 10.3390/MOLECULES28217412.
[29] Rangkaew, R. Suttisri, M. Moriyasu, and K. Kawanishi, “A new acyclic diterpene acid and bioactive compounds from Knema glauca”, Arch Pharm Res, vol. 32, no. 5, pp. 685–692, 2009, doi: 10.1007/S12272-009-1506-5.
[30] H. Lee et al., “Isolation and Identification of an Antiproliferative Compound from Fructose-Tryptophan Maillard Reaction Products”, J Agric Food Chem, vol. 64, no. 15, pp. 3041–3047, 2016, doi: 10.1021/ACS.JAFC.6B00157.
[31] H. Nguyen et al., “Ellagitannin and flavonoid constituents from Agrimonia pilosa Ledeb. with their protein tyrosine phosphatase and acetylcholinesterase inhibitory activities”, Bioorg Chem, vol. 72, pp. 293–300, 2017, doi: 10.1016/J.BIOORG.2017.04.017.
[32] S. Krishna, B. Joy, and A. Sundaresan, “Effect on oxidative stress, glucose uptake level and lipid droplet content by Apigenin 7, 4’-dimethyl ether isolated from Piper longum L”, J Food Sci Technol, vol. 52, no. 6, pp. 3561–3570, 2015, doi: 10.1007/S13197-014-1387-6.
[33] T. Takimoto, K. Suzuki, H. Arisaka, T. Murata, H. Ozaki, and N. Koyama, “Effect of N-(p-coumaroyl)serotonin and N-feruloylserotonin, major anti-atherogenic polyphenols in safflower seed, on vasodilation, proliferation and migration of vascular smooth muscle cells”, Mol Nutr Food Res, vol. 55, no. 10, pp. 1561–1571, 2011, doi: 10.1002/MNFR.201000545.
Xem thêm
##plugins.themes.academic_pro.article.sidebar##
Đã Xuất bản
Jun 30, 2024
Download
Cách trích dẫn
Tran, T. H., T. N. H. Phan, N. T. N. Hoang, và T. P. T. Doan. “Identification of Potential Inhibitors of Human Aldose Reductase from Natural Compounds of Vietnamese Medicinal Plants Using in Silico Approaches”. Tạp Chí Khoa học Và Công nghệ - Đại học Đà Nẵng, vol 22, số p.h 6B, Tháng Sáu 2024, tr 27-31, doi:10.31130/ud-jst.2024.038E.
